In the past 50 years organ transplantation has been established as an extremely important branch of therapeutic medicine, starting from nothing in the 1950s to the achievement.
Transplantation informatics is a complex information based field that uses multichannel health information technology in order to improve patient health care.
Induction immunosuppression is not a compulsory stage of immunosuppressive treatment in renal transplant recipients; however, it is often considered essential to improve .
Renal transplantation is the best treatment for ESKD in pediatric as better patient survival, better quality of life (Dialysis is more disruptive to family lifestyle.
The goal of pancreas transplantation is to induce long-lasting complete insulin independence and normal glucose metabolism in type 1 diabetic patients.
Donor specific HLA antibodies have been associated with acute and chronic rejection of organ allograft [1-3]. However, this correlation is not absolute.
Kidney transplantation is one of therapeutic choice for patients with End-Stage Renal Disease (ESRD).
Immunohistochemistry for cell phenotype, viruses when required. Immunohistochemistry for C4d on paraffin if immunofluorecence was unavailable.
Vaccination of immuno-compromised patients is important because impaired host defenses.
Hepatitis C Virus (HCV) is its most leading cause of hepatic disease post renal transplantation.
Recurrent glomerulonephritis following kidney transplantation affects between 10% and 20% of patients, and accounts for up to 8% of graft failures at 10 years Post transplant.
Kidney transplantation is generally accepted as the best treatment for patients with End Stage Renal Disease (ESRD) requiring renal replacement therapy which improves both the quality of life and life span of patients.
Renal transplantation is considered the surgical procedure used in renal replacement therapy.
Post-doctorate, Urology and Nephrology Center, Mansoura, Egypt
I was graduated from my home city Mansoura University, Faculty of Medicine 1993 with grade of honor. I was lucky to start my residency at Nephrology at Urology & Nephrology center, Mansoura, Egypt. After achieving Master degree in general medicine and nephrology I was granted a nephrology fellowship in transplantation in the same center. Then I received a fellowship grant from the international society of nephrology (ISN) to have training in transplantation immunology with Professor Kathryn wood, one of the greatest mentors in transplantation science research, at Transplantation Research Immunology Group, Nuffield Department of Surgery, Oxford University, United Kingdom. My focus was on the investigation of the cellular mechanisms of graft tolerance. During my training, I received Distinguished Fellow’s Award recognition for my work from the ISN, plus many accepted publication and Chapter in one of the prestigious Textbooks in Inflammation. Once I finished my doctoral degree in Egypt, I continued my transplantation clinical practice, during that period I have focused my research in artificial intelligence and multivariate models to predict long-term graft survival. After two years of clinical practice I moved to France to start post-doctoral fellowship in Transplantation science for two years with Prof. Jean-Paul Soulillou and Dr. Sophie Brouard, Nantes University, France and the division of Nephrology, Northwestern University, USA. My knowledge and orientation was shifted from T cells mechanisms of rejection and tolerance to B cells mediated rejections. Beside that I have participated in many clinically applicable biostatistical models and several clinical publications in Transplantation and Cancer. Transplantation science is my passionate, surfing between the barriers & risks and searching for solutions with new modifications of our approaches to deliver the best aid to those humans unluckily been found to have one of their organs stopped.